Trigeminal neuralgia treatment in Turkey | Diagnosis & Relief

What exactly is trigeminal neuralgia and Why is it so hard to diagnose?

The trigeminal nerve (cranial nerve V) is the primary sensory nerve of the face. It divides into three branches:

• The ophthalmic (V1, forehead and eye area).
• The maxillary (V2, cheek and upper jaw).
• The mandibular (V3, lower jaw and chin).

When a blood vessel, most commonly the superior cerebellar artery, presses against the nerve root as it exits the brainstem, it erodes the myelin sheath, the insulating layer around the nerve. The result is abnormal electrical discharges, which produce sudden, explosive facial pain.

The condition affects approximately 12 per 100,000 people annually, according to epidemiological data published in the journal Cephalalgia. Women are slightly more affected than men. The average age of onset is 53, though younger patients and even children can develop it, particularly when an underlying cause like multiple sclerosis is present

Diagnosis is notoriously delayed, studies estimate an average of 3.5 years from first symptom to correct diagnosis. The condition mimics dental pain, sinusitis, temporomandibular joint (TMJ) disorder, and atypical facial pain. Many patients undergo unnecessary dental extractions or sinus procedures before a neurologist correctly identifies the source.

Key diagnostic criteria (ICHD-3, 2018): Recurrent unilateral facial pain in one or more trigeminal nerve distributions; sudden onset and termination; pain provoked by innocuous stimuli (trigger zones); no neurological deficit on examination. MRI is recommended to rule out structural causes.

What are the symptoms of trigeminal neuralgia?

Trigeminal neuralgia typically presents with sudden, intense facial pain that patients often describe as one of the most severe types of pain known in medicine. The condition affects one side of the face and is characterized by brief but extremely painful attacks that can significantly impact daily life.

Typical symptoms include:

• Sudden, severe, electric shock-like or stabbing pain on one side of the face, lasting from a fraction of a second to about 1-2 minutes
• Pain affecting areas such as the cheek, jaw, teeth, gums, lips, and sometimes the eye or forehead
• Pain episodes triggered by everyday activities such as light touch, chewing, speaking, brushing teeth, or exposure to cold wind
• Pain-free intervals between attacks, which may become shorter over time as the condition progresses
• In some patients, a persistent dull or burning ache between attacks (often referred to as atypical or Type 2 trigeminal neuralgia),which may be less responsive to standard treatments

Because attacks are unpredictable and extremely painful, many patients gradually develop behavioral changes such as avoiding eating, speaking, or touching the face. Over time, this can lead to social withdrawal, weight loss, anxiety, and emotional distress.

What causes trigeminal neuralgia?

In most cases, trigeminal neuralgia develops when a blood vessel presses against the trigeminal nerve near the brainstem. This constant pulsation can gradually damage the nerve's protective coating (myelin),leading to abnormal pain signals and sudden facial pain attacks.

The most common causes include:

• Vascular compression (85-90% of cases): most often caused by the superior cerebellar artery, although other arteries or veins may also be involved.
• Multiple sclerosis (2-4% of cases): demyelinating lesions near the trigeminal nerve can trigger symptoms, particularly in younger patients.
• Benign tumours: such as meningiomas, vestibular schwannomas (acoustic neuromas),or epidermoid cysts compressing the nerve.
• Arteriovenous malformations (AVMs): abnormal blood vessel connections located near the brainstem.
• Post-herpetic neuralgia: pain following shingles (herpes zoster) affecting the trigeminal nerve. This is a distinct condition but may produce similar symptoms.

In approximately 10-15% of patients, MRI scans do not reveal any identifiable structural cause. These cases are classified as idiopathic trigeminal neuralgia

How is trigeminal neuralgia diagnosed in Turkey?

Diagnosis in Turkish JCI-certified hospitals follows an evidence-based protocol, combining clinical assessment with advanced neuroimaging:

1. Neurological consultation: Detailed history of pain onset, location, duration, triggers; full cranial nerve examination, including facial sensation in all three trigeminal divisions, corneal reflex, and masseter strength.
2. High-resolution MRI: 3T MRI with specific protocols (FIESTA/CISS sequences) to visualize the trigeminal nerve root and identify neurovascular compression, the gold standard imaging for TN. Available at all partner hospitals!
3. CT Scan: Used when MRI is contraindicated (pacemaker, severe claustrophobia),or to assess bony structures.
4. Trigeminal reflex testing (Blink Reflex / R1 response): Electrophysiological test to assess trigeminal pathway integrity, particularly useful in atypical presentations or to support surgical planning.
5. Differential diagnosis workup: Dental X-rays, panoramic OPG, ENT evaluation to exclude dental abscess, sinusitis, and TMJ disorder as alternative diagnoses.

Turkish neurologists and neurosurgeons use the Barrow Neurological Institute (BNI) Scale and the Penn Facial Pain Scale to quantify pain severity and track treatment response over time, standardized tools that allow meaningful comparison of outcomes across institutions.

What are the treatment options for trigeminal neuralgia available in Turkey?

Treatment follows a stepwise approach: medications first, then minimally invasive procedures, then surgery. The right option depends on your age, general health, TN type (vascular compression vs. MS-related vs. idiopathic),pain severity, and whether previous treatments have failed.

Pharmacological management (First-line treatment)

Important note: Drug treatment for TN requires regular blood monitoring, particularly for sodium levels (hyponatremia) and liver function. Turkish clinics can provide pre-procedure lab work as part of their diagnostic package.

Interventional and surgical procedures

When medication provides inadequate relief or causes intolerable side effects, interventional procedures offer long-term pain control. Turkey's neurosurgical centres perform all of the following:

Microvascular decompression (MVD): The gold standard

MVD is the only procedure that addresses the root cause of TN (vascular compression) rather than ablating or damaging the nerve. Through a small retro-auricular craniotomy, the neurosurgeon identifies the offending vessel under microscopic vision and places a Teflon pad between it and the nerve, relieving compression.

• Best candidates: Younger patients (under 65-70) in good general health, confirmed vascular compression on MRI, classical TN (Type 1)
• Efficacy: 85-90% of patients achieve immediate excellent pain relief (BNI I-IIIa). Long-term freedom from pain at 10 years: approximately 68-75% (Sekula et al., Neurosurgery 2019)
• Recurrence: 20-30% over 10 years, lowest recurrence rate of all procedures
• Hospital stay: 3-5 days. Return to normal activities: 3-4 weeks

Percutaneous radiofrequency rhizotomy (RFR)

A needle is passed through the cheek into the trigeminal ganglion under fluoroscopic guidance. Controlled heat lesioning selectively damages pain fibres while preserving touch sensation.

• Best candidates: Older patients, poor surgical candidates, failed MVD, MS-related TN
• Efficacy: 80-90% immediate relief. Recurrence: 40-50% at 10 years
• Duration: Outpatient procedure, 1-2 hours. Recovery: 1-2 weeks

Gamma knife radiosurgery

Highly focused radiation beams target the trigeminal nerve root at the brainstem. No incision, no anaesthesia required.

• Best candidates: Patients not suitable for open surgery, anticoagulated patients, elderly patients, those wanting the least invasive option
• Efficacy: 70-80% of patients achieve meaningful pain relief. Onset: 1-4 months after treatment
• Recurrence: Approximately 50% at 5 years, higher than MVD
• Side effect: Facial numbness (up to 30% of patients); considered acceptable by most as it replaces agonising pain

Balloon microcompression

A balloon catheter is inflated in Meckel's cave to compress the trigeminal ganglion, selectively damaging pain fibres.

• Best candidates: Patients with V1 (ophthalmic) involvement (avoided with RFR due to corneal anaesthesia risk),older or frailer patients
• Efficacy: 75-85% immediate relief. Recurrence rate similar to RFR
• Key risk: Masticatory weakness (jaw muscles) in up to 50% of patients, usually temporary

Glycerol rhizotomy

Injection of sterile glycerol into the trigeminal cistern, which gradually damages pain fibres. Less commonly performed but offers an additional option when other procedures have failed.

• Efficacy: 60-80% initial relief. Recurrence rates are higher than MVD and RFR
• Advantage: Low risk profile, no radiation, can be repeated

What are the risks and complications of each treatment?

Every treatment for trigeminal neuralgia involves trade-offs between pain relief, side effects, and recurrence. Here is a frank, evidence-based overview of specific risks by modality, information that international patients have a right to understand before making a decision.

Microvascular decompression

• Hearing loss: 1-3% (due to proximity of the auditory nerve). Intraoperative auditory monitoring (BAER) is performed in all reputable Turkish neurosurgical centers to minimize this risk.
• Facial numbness: 4-7% of patients develop some degree of facial sensory change.
• CSF leak: 1-2%, usually manageable conservatively or with a short lumbar drain.
• Meningitis (aseptic or bacterial): Under 1% in JCI-certified centers with strict sterile technique.
• Stroke or serious neurological complication: Under 0.5% in experienced hands (>50 MVD procedures/year).
• General anesthesia risks: Standard risks apply, particularly in elderly patients with comorbidities.

Radiofrequency rhizotomy

• Facial numbness: Very common (60-80%),The procedure deliberately damages nerve fibers, and numbness is expected to some degree.
• Corneal anesthesia (V1 branch): Risk of keratitis and corneal ulcer if the ophthalmic branch is treated; requires ophthalmological follow-up.
• Dysesthesia (painful numbness/anesthesia dolorosa): 5-10%, a particularly difficult-to-treat complication where the numb area becomes spontaneously painful
• Masticatory weakness: Temporary jaw muscle weakness in some patients

Gamma knife radiosurgery

• Facial numbness: 20-30% of patients at 6-12 months post-treatment, usually mild to moderate
• Treatment failure: 20-30% of patients do not achieve adequate relief, particularly with MS-related TN.
• Delayed radiation effects: Rare but possible; the long-term safety profile beyond 10 years remains under study.
• Re-treatment: Can be performed, but carries higher risk of numbness with each session

Balloon microcompression

• Masticatory weakness (chewing difficulty): Up to 50% of patients experience temporary masseter weakness; usually resolves within 3-6 months.
• Bradycardia: Intraoperative heart rate slowing (trigeminal-vagal reflex),managed with atropine; relevant in patients with cardiac history
• Facial numbness: Expected in most patients (similar to RFR).

All surgical procedures at Turquie Santé partner hospitals are performed by neurosurgeons with a minimum of 10 years' experience in cranial nerve surgery. Complication rates should be specifically discussed with your surgeon before any procedure. Ask for your surgeon's personal complication data, not just the hospital's aggregate statistics.

What does the patient journey look like from abroad?

From first contact to returning home, Turquie Santé manages every step:

1. You submit your request online with your medical documents (MRI, neurology reports, previous treatments).
2. Within 48 hours, a coordinator contacts you to discuss your case and request any missing information.
3. A neurosurgeon reviews your file and provides a personalized treatment recommendation and cost estimate.
4. You confirm the appointment; Turquie Santé assists with your Turkish medical visa, if required.
5. Upon arrival in Istanbul (or Ankara/Antalya),VIP airport transfer to your hotel or hospital.
6. Pre-surgical consultation and any additional imaging completed on day 1-2.
7. Procedure performed; hospital stay as required (1-5 days, depending on treatment).
8. Post-operative review before departure; medical report and prescription in English provided.
9. Remote follow-up consultations at 2 weeks, 6 weeks, and 3 months after return.

All medical documents, diagnosis, surgical report, medication list, follow-up instructions are provided in English as standard, with certified translation in other languages on request.